Dec 31, 2012

Neurocrine Biosciences Q4 2012 Earnings Report

Total Revenue
$21.9M
Previous year: $11.1M
+97.5%
EPS
$0.14
Previous year: $0.02
+600.0%
Gross Profit
$21.9M
Previous year: $11.1M
+97.5%
Cash and Equivalents
$63.8M
Previous year: $50.1M
+27.2%
Free Cash Flow
-$8.95M
Previous year: $11M
-181.4%
Total Assets
$196M
Previous year: $138M
+41.6%

Neurocrine Biosciences

Neurocrine Biosciences